Clinical Trials
42 trialsSHIP-A-S01
National Cancer Institute (NCI)
LMI-001-A-S03
National Cancer Institute (NCI)
LMI-001-A-S02
National Cancer Institute (NCI)
LMI-001-A-S04
National Cancer Institute (NCI)
Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
Timser SAPI de CV
Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population
Timser SAPI de CV
EQUIP
Qurasense
OPTICS
DL Analytics
CAMPO-101
University of California, San Francisco
HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV
Montefiore Medical Center
Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya
UNC Lineberger Comprehensive Cancer Center
DiaVACCS
University of Pretoria
Clinical Triage and Treatment of Atypical Glandular Cells (AGC) Detected in Screening
Karolinska Institutet
AI Model for Cervical Cancer Detection From Colposcopy Images
Bangladesh University of Engineering and Technology
Diagnosis of Cervical Lesions in Women With Unhealthy Looking Cervix
Assiut University
MTTRIHPW
Obstetrics & Gynecology Hospital of Fudan University
CESTA
International Agency for Research on Cancer
Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue
University of New Mexico
Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens
Hologic Deutschland GmbH
Intended Use Study of the BD SurePath Plus™ Pap
Becton, Dickinson and Company
Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical Dysplasia
M.D. Anderson Cancer Center
Clinical Validation of Cervical Cancer Screening Methods
N.N. Petrov National Medical Research Center of Oncology
Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens
Becton, Dickinson and Company
LLETZ Under Direct Colposcopic Vision
Zydolab - Institute of Cytology and Immune Cytochemistry
Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology
Bezmialem Vakif University
Colpo
University of Virginia
ASCUS-COL
Universidad de Antioquia
Comparison of Cervical Pathologies in the Presence of High Risk Hpv Positivity
Kanuni Sultan Suleyman Training and Research Hospital
Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)
National Institutes of Health Clinical Center (CC)
Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens
Becton, Dickinson and Company
Post Colposcopy Management of ASC-US and LSIL Pap Tests
University of Calgary
Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples
Becton, Dickinson and Company
The Study of Folate Receptor-Mediated Staining Solution (FRD™) In Cervical Lesion Detection
GY Highland Biotech LLC
Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia
British Columbia Cancer Agency
SAGE
British Columbia Cancer Agency
Spectroscopy Versus Standard Care in Cervical Cancer Patients
M.D. Anderson Cancer Center
CHICAPS
Preventive Oncology International, Inc.
Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening
National Cancer Institute (NCI)
Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia
M.D. Anderson Cancer Center
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer
Northwestern University
Diagnostic and Prognostic Value of p16INK4a Expression in Low Grade Squamous Intraepithelial Lesions of the Cervix.
University Hospital, Strasbourg, France
Spectroscopy in Diagnosing Dysplasia and Neoplasia in the Cervix in Women Undergoing Colposcopy
National Cancer Institute (NCI)